top of page

MBA Internship (Strategy)
- Calla Lily Clinical Care

Apply Now

London, UK

Job Type



About the Role

We’re looking for MBA interns to support CLCC across our strategy and fundraising functions and who want an immersive experience in a lean, high potential & very purpose-driven medical devices start-up.

- Develop strategies and business plans focussed on various health conditions / indications for our novel platform technology
- Contribute to assessments of and discussions with potential strategic partners for CLCC
- Help refine Company’s fundraising strategy, developing pipeline of women’s health & impact focused investors in Europe, US, Middle East and Asia
- Refine fundraising pitch messaging and materials
- Refine a forecasted budget to facilitate sound, quick decision making
- Estimate TAM, SAM and SOM of different use cases
- Work directly with CLCC’s CEO and CFO


  • Enrolled in a top MBA program with a passion for women’s health (pre-MBA or post-MBA positions also considered)

  • Able to demonstrate an ability to quickly grasp the key drivers for a medical device start-up

  • A catalyst for change: we like individuals who bring a unique perspective and can improve how we operate

  • Analytical: we like big ideas and want to be able to quantify opportunities as well as execute on them

  • Action-oriented: time is our scarcest asset and as such we need to balance planning with execution

About the Company

Calla Lily Clinical Care is an award-winning women’s health company developing products for intravaginal drug delivery, based upon our proprietary Callavid® platform device technology. Initial target indications are in IVF and prevention of preterm birth and miscarriage. We are also exploiting our device’s unique potential to reliably deliver live biotherapeutics (LBPs) to restore a healthy vaginal microbiome - for example to address bacterial vaginosis (BV) which impacts fertility, and where current treatment methods lead to high recurrence, necessitating repeated courses of antibiotics and contributing to the growth of antimicrobial resistance (AMR).

Further use-cases for our patented technology include effective sample collection to facilitate the next generation of biomarker-based diagnostic tests for endometriosis and a range of other conditions.

Our patented technology has received FDA clearance and was named one of TIME magazine’s Best Inventions of the Year, and our team has been named in the top 10 in Fast Company’s annual list of Most Innovative Companies in the World. We’re a Certified B-Corp balancing people, planet, and profit - and are looking for exceptional, dynamic, proactive people who want to make a difference in women’s health.

bottom of page